RION CoFRA:G73 +2.97%60 EBITDA Margin % is 33.84% as of Mar. 2026, which is 109% above its 10-year median of 16.23. GuruFocus rates FRA:G73 with a GF Score™ of 60/100 and a GF Value™ of €14.25 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 816 Medical Devices & Instruments companies, RION Co ranks better than 76.1% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. RION Co's EBITDA for the
three
months ended in Mar. 2026 was €14.7 Mil. RION Co's Revenue for the
three
months ended in Mar. 2026 was €43.3 Mil. Therefore, RION Co's EBITDA margin for the quarter that ended in Mar. 2026 was 33.84%.
RION Co (FRA:G73) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
RION Co EBITDA Margin % Related Terms
RION Co EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for RION Co's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:G73 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, RION Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RION Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RION Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where RION Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RION Co (FRA:G73) has a EBITDA Margin % of 33.84% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on RION Co and its competitors. This is 109% above median its historical median of 16.23. Over the past decade, RION Co's EBITDA Margin % has ranged from 13.12 to 20.28. According to the industry distribution chart, RION Co ranks #195 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is RION Co's EBITDA Margin % too high?
RION Co's current EBITDA Margin % of 33.84% is 109% above median its 10-year median of 16.23. Over the past 10 years, this metric has ranged from a low of 13.12 to a high of 20.28. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. RION Co's value of 33.84% is 352.7% above this industry median. Based on the distribution chart, RION Co ranks #195 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, RION Co has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RION Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, RION Co ranks #195 out of 816 companies for EBITDA Margin %. This places RION Co in the top 24% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. RION Co's value of 33.84% is 352.7% above this benchmark. Historically, RION Co's own EBITDA Margin % has ranged from 13.12 to 20.28 over the past decade. While the company's 10-year median is 16.23 vs. the industry median of 7.48, RION Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RION Co's current EBITDA Margin % of 33.84% is 352.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on RION Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RION Co's current EBITDA Margin % is 33.84%, which is 109% above median its own 10-year median of 16.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RION Co stock overvalued right now?
Based on GuruFocus' analysis, RION Co (FRA:G73) is currently considered Significantly Overvalued. The stock's GF Value™ is €14.25, compared to a current price of €20.80 — trading 46% above its estimated fair value. The current EBITDA Margin % is 33.84%, which is 109% above median its 10-year median of 16.23 and 352.7% above the Medical Devices & Instruments industry median of 7.48. RION Co's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For RION Co (FRA:G73), the current EBITDA Margin % is 33.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RION Co (FRA:G73) Overvalued in 2026?
Based on GuruFocus' analysis, RION Co stock appears to be overvalued.
The current stock price of €20.80 is trading 46% above its estimated GF Value™ of €14.25.
GuruFocus considers RION Co to be Significantly Overvalued.
Key valuation signals for FRA:G73:
EBITDA Margin %: 33.84% (109% above median its 10-year median of 16.23)
GF Value™: €14.25 vs. price of €20.80 (46% above fair value)
Industry Position: 352.7% above the Medical Devices & Instruments median (#195 of 816)
No single metric tells the full story. See the FRA:G73 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RION Co Ltd is engaged in manufacturing and selling of maintenance services of a medical device. The company offers hearing instruments and medical equipment, an environmental device including sound and vibration measuring instruments and particle counters and parts and equipment.
60GF Score
Get the complete analysis for FRA:G73
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:G73 has been successfully added to your 
